Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prime Medicine (PRME) Change in Account Payables: 2021-2025

Historic Change in Account Payables for Prime Medicine (PRME) over the last 4 years, with Sep 2025 value amounting to $3.0 million.

  • Prime Medicine's Change in Account Payables rose 100.79% to $3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.0 million, marking a year-over-year increase of 174.24%. This contributed to the annual value of -$5.3 million for FY2024, which is 157.52% down from last year.
  • Latest data reveals that Prime Medicine reported Change in Account Payables of $3.0 million as of Q3 2025, which was up 190.82% from -$3.3 million recorded in Q2 2025.
  • Over the past 5 years, Prime Medicine's Change in Account Payables peaked at $5.8 million during Q3 2023, and registered a low of -$5.9 million during Q1 2024.
  • Moreover, its 3-year median value for Change in Account Payables was $1.6 million (2023), whereas its average is $496,364.
  • Per our database at Business Quant, Prime Medicine's Change in Account Payables surged by 1,535.66% in 2023 and then tumbled by 1,066.67% in 2024.
  • Over the past 5 years, Prime Medicine's Change in Account Payables (Quarterly) stood at $80,000 in 2021, then surged by 438.75% to $431,000 in 2022, then skyrocketed by 428.77% to $2.3 million in 2023, then grew by 7.94% to $2.5 million in 2024, then skyrocketed by 100.79% to $3.0 million in 2025.
  • Its last three reported values are $3.0 million in Q3 2025, -$3.3 million for Q2 2025, and $1.9 million during Q1 2025.